0001656472-23-000104.txt : 20230601 0001656472-23-000104.hdr.sgml : 20230601 20230601162850 ACCESSION NUMBER: 0001656472-23-000104 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230522 FILED AS OF DATE: 20230601 DATE AS OF CHANGE: 20230601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGinness James Andrew III CENTRAL INDEX KEY: 0001871471 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 23985114 MAIL ADDRESS: STREET 1: C/O MARKETWISE STREET 2: 1125 N. CHARLES STREET CITY: BALTIMORE STATE: MD ZIP: 21201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 3 1 wf-form3_168565131490525.xml FORM 3 X0206 3 2023-05-22 1 0001656472 Cronos Group Inc. CRON 0001871471 McGinness James Andrew III 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 VP, Controller /s/ Andrew Davisson as attorney-in-fact 2023-06-01 EX-24 2 section16poaformcginness.htm MCGINNESSPOA

James A. McGinness III  Exhibit 24


Authorization and Designation
to Sign and File
Section 16 Reporting Forms



    The undersigned, an officer of Cronos Group Inc., a corporation incorporated under the Business Corporations Act (British Columbia) (the "Company"), does hereby authorize and designate Terry Doucet, Andrew Davisson and Aaron Werner, each with right to substitute and resubstitute, but for only so long as each of them is an employee of the Company, to sign and file on his behalf the application for the required Securities and Exchange Commission ("SEC") electronic CIK/CCC codes and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934 ("Section 16") and Rule 144 under the Securities Act of 1933, as amended.  This authorization, unless earlier revoked in writing, shall be valid until the undersigned's reporting obligations under Section 16 and Rule 144 with respect to equity securities of the Company shall cease.  All prior such authorizations are hereby revoked.

    IN WITNESS WHEREOF, the undersigned has executed this Authorization and Designation this 31st day of May, 2023.




                              /s/ James A. McGinness III
                            James A. McGinness III